Oracle Partners

Biolase ex-CEO demands answers following his board resignation

August 14, 2014 By Arezu Sarvestani Leave a Comment

Biolase ex-CEO demands answers following his resignation

Former Biolase (NSDQ:BIOL) CEO Federico Pignatelli isn’t ready to put down his dukes after dropping his seat on the company’s board of directors.

Biolase ex-CEO Pignatelli ditches the board

August 7, 2014 By Arezu Sarvestani Leave a Comment

Biolase ex-CEO Pignatelli steps down from board

Former Biolase (NSDQ:BIOL) CEO Federico Pignatelli, who was removed from the corner office by a court order earlier this year, also walked away from the company’s board of directors.

Ex-Biolase CEO isn’t giving up without a fight

June 28, 2014 By Arezu Sarvestani Leave a Comment

Ex-Biolase CEO isn't giving up without a fight

Shares of Biolase (NSDQ:BIOL) got a modest boost today, even as a company insider announced a far-reaching investigation into the company’s management under the suspicion of wrongdoing.

CEO Pignatelli out after court-ordered shake-up at Biolase

June 17, 2014 By Brad Perriello Leave a Comment

CEO Pignatelli out in court-ordered shakeup at Biolase

The boardroom and C-suite at Biolase (NSDQ:BIOL) got a shake-up this week following a Delaware Supreme Court decision in a lawsuit filed by Oracle Partners earlier this year.

Boston Scientific’s peripherals buy bad news for Cardiovascular Systems? | Medtech Wall Street news for the week of May 19, 2014

May 22, 2014 By MassDevice Leave a Comment

Is Boston Scientific's peripherals buy bad news for Cardiovascular Systems?

May 15, 2014 by Arezu Sarvestani

Is Boston Scientific's peripherals buy bad news for Cardiovascular Systems?

Activist investor Oracle revives proxy war at Biolase

May 19, 2014 By Arezu Sarvestani Leave a Comment

Activist investor Oracle revives proxy war at Biolase

Judge cuts Biolase board of directors | Medtech legal news for the week of Mar. 31, 2014

March 31, 2014 By MassDevice staff Leave a Comment

UPDATE: Court cuts Biolase board, marketing VP under fire

March 24, 2014 by Arezu Sarvestani

Court halves Biolase board, marketing VP under fire

Biolase board of directors cut by DE judge | Medtech personnel moves for the week of Mar. 24, 2014

March 26, 2014 By MassDevice staff Leave a Comment

UPDATE: Court cuts Biolase board, marketing VP under fire

March 24, 2014 by Arezu Sarvestani

Court halves Biolase board, marketing VP under fire

UPDATE: Court cuts Biolase board, marketing VP under fire

March 24, 2014 By Arezu Sarvestani Leave a Comment

Court halves Biolase board, marketing VP under fire

*Updated March 25, 2014 at 10 a.m. Eastern with comment from Biolase sales & marketing vice president Brian Jaffe.

Former CEO sued by InVivo Therapeutics | Medtech legal news for the week of Mar. 24, 2014

March 24, 2014 By MassDevice staff Leave a Comment

InVivo Therapeutics sues ex-CEO Reynolds

March 18, 2014 by Brad Perriello

InVivo Therapeutics sues ex-CEO Reynolds

K2M Group Holdings looks to raise $100M in IPO | Medtech Wall Street stories for the week of Mar. 17, 2014

March 19, 2014 By MassDevice staff Leave a Comment

Spinal firm K2M aims for $100M IPO

March 14, 2014 by Arezu Sarvestani

Spinal firm K2M aims for $100M IPO

Market Summary > Current Price

The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.